in a minority of patients. The distance between anal verge and the caudal edge of the tumour was assessed by proctoscopy and/or digital examination. All tumours were classified according to the TNM system of the Union International Contre le Cancer (1992) . The preoperative tumour classification was determined using information from the digital examination (including assessment of mobility), CT scan and/or transrectal ultrasound, when available. Pretreatment patient characteristics are displayed in Table 1 .
Preoperative therapy
All patients were treated with external megavoltage (6-18 MV) photon beams. A 3-or 4-field technique was used in most patients, except for seven patients treated with opposed antero-posterior pelvic fields. The median dose to the pelvic volume was 45 Gy in 25 fractions over 5 weeks (range 25.2-50.4 Gy). Ten patients received a boost of 5.4 Gy in 3 fractions directed to the tumour with 2-3 cm margin to attain a total tumour dose of 50.4 Gy. During RT, 30 patients received 5-fluorouracil (5-FU)-based chemotherapy, either in daily continuous administration (16 patients), or as intravenous (i.v.) bolus for 3-5 days during weeks 1 and 5 (14 patients). After surgery, patients with pathological nodal involvement or distant metastasis usually received postoperative 5-FU-based chemotherapy.
Surgery
Surgery was performed at a median interval of 29 days (range 12-96 days) from completion of RT. While surgery was recommended to be carried out 4-6 weeks after RT, some patients were operated on either earlier or later, mainly due to patient preferences. APR was carried out in 29 patients, low anterior resection (LAR) in 23 patients (20 with coloanal and three with colorectal anastomoses) and transrectal excision in one patient. A temporary transverse colostomy was performed in 13 patients and a J colonic pouch in 14 patients. Of three patients found to have hepatic metastases at surgery, one underwent apparently complete resection of liver metastases.
In patients undergoing LAR with coloanal anastomosis, the technique was standardized according to the following steps: the left colon with the splenic flexure was mobilized after ligature and section of the inferior mesenteric vein and artery. The mesosigmoid was then mobilized and the plane of the mesorectum was entered in continuity as the dissection proceeded distally. This plane was followed down to the level of the pelvic floor when a total mesorectal excision (TME) was performed (Heald and Ryall, 1986) . The dissection of the rectum and mesorectum was performed applying slight lateral traction to open the cleavage plane between the mesorectum and the lateral wall of the pelvis. This allowed clear visualization and preservation of the pelvic autonomic nerves. Most patients operated on with TME have had a defunctioning transverse colostomy.
Anal function assessment
Anal sphincter function was evaluated according to the Memorial Sloan-Kettering Cancer Center (MSKCC) anal function criteria (Minsky et al, 1995) . The score 'excellent' corresponds to 1-2 bowel movements per day and no soilage; 'good' corresponds to 3-4 bowel movements per day and/or mild soilage; 'fair' corresponds to more than 4 bowel movements per day and/or moderate soilage, and 'poor' corresponds to incontinence. Acute and late RT-related complications were classified according to the RTOG grading system (Perez and Brady, 1992) .
QOL assessment
Patients were selected for QOL assessment if they had 1-year minimum follow-up, did not present uncontrolled locoregional failure, were not under treatment for distant metastases and accepted participation in the study. QOL was assessed by using two questionnaires developed by the QOL Study Group of the European Organization for Research and Treatment of Cancer: a validated questionnaire assessing cancer-specific QOL (EORTC QLQ-C30) (Aaronson et al, 1993) and one assessing site-specific (colorectal) QOL (EORTC QLQ-CR38), which is in the process of validation.
EORTC QLQ-C30
This is a patient self-rating questionnaire that comprises six function scales measuring physical, role, social, emotional and cognitive functions, and overall QOL, as well as symptom scales assessing pain, fatigue, emesis, bowel function, dyspnoea, appetite loss and sleep disturbances. A final item evaluates the perceived economic impact of the disease.
EORTC QLQ-CR38
This module is a patient self-rating questionnaire that comprises 38 questions, of which 19 are completed by all patients and the remaining by subset of patients (males or females; patients with or without a stoma). The general structure comprises four multiitem/single-function scales (assessing body image, sexual functioning, sexual enjoyment and future perspective), seven symptom scales (assessing radiotherapy side-effects on micturition, chemotherapy side-effects, gastrointestinal general symptoms, defecation problems, stoma-related problems and sexual dysfunction in males or females) and one single-symptom item assessing weight loss. This module has been validated in The Netherlands and is currently being used in a wide range of cross-cultural studies (Sprangers et al, 1999) . 
Statistical analyses
Actuarial locoregional control, overall and disease-free survival rates were calculated by the product-limit method (Kaplan and Meier, 1958) . The log-rank test was used to compare survival curves, the Mann-Whitney U-test to compare median scores of QOL scales (considering the non-Gaussian distribution of these scores), and the Student's t-test to compare the means of the remaining outcome variables. A difference with a P-value р 0.05 was considered as significant. All scores of the QLQ-C30 and QLQ-CR38 were linearly transformed such that all scales range from 0 to 100. The higher scale score represents a higher level of functioning for the six (QLQ-C30) and four (QLQ-CR38) multi-item/single-function scales and a higher level of symptomatology/problems for the symptom/single-item scales. We hypothesized that at least some scores of the various scales would vary between subgroups of patients according to the type of surgery, particularly levels of physical and social functions, overall quality of life, body image and sexual functioning that were expected to be higher in patients with a conserved anal sphincter.
RESULTS

Pathologic findings
At pathological evaluation of the resection specimen, 12 patients (22.5%) had a marked response to preoperative therapy, including four patients (7.5%) with a microscopically complete response, and eight (15%) with only microscopically residual carcinoma. The remaining 41 patients had a partial response or no change. Post-RT pathological tumour stages were four pT0, four pT1, 16 pT2, 24 pT3 and five pT4. Sixteen patients had positive lymph nodes (13 pN1 and three pN2), and three patients had hepatic metastases. All patients with positive nodes or distant metastases had partial response or no change of their primary tumour after RT. The mean interval between RT and surgery was 42 days for patients having complete pathological response or microscopic residual disease, compared with 33.5 days for patients with partial response or no change (P = 0.15). For patients undergoing LAR, the mean pathologic distal free margin was 2.2 cm (standard deviation (s.d.) 1.24, range 0.3-4 cm). Surgical margins were negative in 49 patients, positive in one and uncertain in three.
Choice of surgical procedure
Indications regarding the type of surgical procedure foreseen was available in the clinical records of all patients prior to RT. APR was planned in 21 patients, a restorative procedure in seven patients, and in 25 patients the decision was intended to be made as a function of the tumour response to preoperative treatment. The final decision was taken by the surgeon in the immediate preoperative period according essentially to the tumour response. Table 2 displays the comparison of the planned type of surgery to the procedure actually performed. The mean distance from the anal verge to the tumour was 3 cm (s.d. 1.45, range 0.5-6 cm) and 4.5 cm (s.d. 1.25, range 1.5-6 cm) in patients operated by APR and LAR respectively (P = 0.0007).
Toxicity
During preoperative therapy, 63% of patients presented with grade 1-2, 33% with grade 3 and one patient with a grade 4 acute toxicity. Acute complications involved the perineal skin in most cases, while diarrhoea, proctitis and urinary tract symptoms (dysuria, urgency, frequency) were commonly observed reactions. The grade 4 toxicity consisted of an acute small bowel obstruction managed conservatively, occurring at a dose of 25.2 Gy delivered by a 2-field technique in a patient receiving a continuous 5-FU infusion (treatment stopped definitively). One grade 3 leukopenia and one case of venous thrombosis were also documented.
Thirteen patients presented with post-operative complications: six in the APR group and seven in the conservation surgery group. There were two abdominal wound dehiscences (one treated surgically), three perineal and three abdominal wound abscesses, one colic ischaemia (treated surgically), one fistula after colostomy closing and three partial anastomotic disruptions (one managed surgically).
During follow-up, two patients from the restorative surgery group required surgical treatment for a late complication. One presented with small bowel obstruction managed surgically, and one presented with a presacral abscess requiring a definitive sigmoidostomy. Among 11 patients having had sphincter-saving surgery with a minimum of 1-year follow-up, the MSKCC anal function score was excellent in seven cases, good in two and fair in two. 
Oncologic results
With a median follow-up of 23 months (range 4-74 months) from the start of RT, nine patients have died: five of rectal cancer, two of a second malignancy, one from intercurrent disease and one from unknown cause. The 3-year actuarial survival for all patients was 71.4% (95% confidence interval (CI) 53-89%). During follow-up, 15 patients presented with disease progression. Locoregional failures were observed in seven patients, either alone (four) or with distant metastasis (three). Distant metastasis alone occurred in nine patients, involving either the lung (seven) or the liver (five). The 3-year actuarial locoregional control rates were 77.5% (95% CI 61-93) for all patients, 100% for the 12 patients with marked pathological tumour response to RT, and 73% for the remaining patients. The 3-year disease-free survival rates were 58% (95% CI 40-75) for all patients, 89% for patients with pathological marked response and 52% for the remaining patients (P = 0.16). According to pathological classification, 3-year disease-free survival rates were 76% and 47% for patients with pT0-2 and pT3-4 tumours respectively (P = 0.057). No significant difference in disease-free survival was observed between patients operated by APR or by restorative surgery (Figure 1) , or between patients receiving preoperative radiotherapy alone and those treated with radiochemotherapy.
QOL outcomes
Twenty-six patients satisfied the inclusion criteria. All patients were contacted by telephone to solicit their participation. Twentythree patients (88%) gave their approval to participate in the study, two refused and one was judged ineligible because of serious comorbidities. Among the 23 participating patients, 11 were treated with APR and 12 with sphincter-sparing surgery. There were 17 males and six females. Age at the time of analysis, the median follow-up time, gender and performance status were similar in the two surgical groups.
EORTC QLQ-C30 scores
The median and mean scale scores according to the type of surgery are given in Table 3 . For all scale scores, no significant differences in medians were observed between the two surgical groups. Patients having undergone restorative surgery tended to report higher levels of constipation (P = 0.09). Although patients having had APR seem to have more sleep disturbances, they tended to report higher levels of physical functioning and global QOL than did patients having had restorative resections.
EORTC QLQ-CR38 scores
The general results for the two surgical groups are given in Table  4 . No significant differences in median scores were observed between the two surgical groups for any of the scales. However, APR group patients tended to report a lower body image score (P = 0.12) but a higher future perspective score. The sexual functioning score was very low in both groups. In males, sexual dysfunction symptom score was higher in the APR group. None of females responded to questions concerning the sexual dysfunction scale. The symptom score related to anorectal function in patients having had restorative surgery was comparable to the symptom score related to the stoma in the subgroup having had APR.
DISCUSSION
In solid tumour oncology the past two decades have been marked by the success of multimodality treatment programmes aiming at respecting body integrity and attempting to preserve organ function. For cancers of the distal rectum the development of such therapeutic approaches in many centres has already resulted in a restriction in the indications for APR. While restorative surgical procedures have long been proposed for highly selected superficial lesions, the availability of sophisticated bowel stapling techniques has allowed restorative procedures to be applied to a much wider spectrum of ( patients with rectal cancers (Papillon and Gerard, 1990; Marks et al, 1993) . Preoperative RT can potentially increase the feasibility of sphincter-saving resections by reducing the tumour volume and by sterilizing local tumour extensions, compensating thereby for the very narrow lateral and caudal resection margins (Papillon and Gerard, 1990; Marks et al, 1993; Rouanet, 1995; Allal, 1996) . The apparently satisfactory oncological results thus obtained, especially when viewed in the light of QOL end points, has led to the increasing use of multimodal restorative approaches.
To assess the incorporation of these therapeutic strategies into our routine practice, we analysed the choice of surgical procedures, oncological results and QOL outcomes in a recent series of 53 patients with cancers involving the distal rectum, the large majority of whom would have been submitted to APR little more than a decade ago (Williams et al, 1983a; Billingham, 1992) . We found that 24 patients (45%) were able to undergo restorative surgical procedures, in 20 cases using LAR with coloanal anastomosis. Moreover, in 25 patients (47%) the decision regarding the type of surgery was not taken at initial surgical consultation, but rather was explicitly based upon the quality of tumour response to preoperative therapy. The proportion of sphincter-saving procedures appears low compared with the 76-83% rates reported in prospective studies of this approach (Minsky et al, 1995; Rouanet et al, 1995; Maghfoor et al, 1997) . However, this apparent discrepancy may be explained by differences in patient selection, particularly regarding tumour stage and distance from the anal verge. Indeed, in the series of Minsky et al (1995) and Rouanet et al (1995) , no patients had T4 tumours or lesions extending below 2.7 cm, whereas in the present series 32% of patients presented clinically with T4 tumours and 28% of patients had tumours extending within 2.7 cm from the anal verge. Our findings are consistent with the 50% rate of restorative resections reported in a large prospective trial studying the value of preoperative therapy in unselected patients with rectal carcinomas (Hyams et al, 1997) .
It is likely in most cases that the distance between the anal verge and the lower edge of the tumour continues to dictate the choice of surgical technique. In the APR group the mean distance between tumour and anal verge was significantly smaller than that of the restorative surgery group (3 cm vs 4.5 cm). Based on operative series, 2 cm is widely considered the minimum distal safety margin (Polett and Nicholls, 1983; Williams et al, 1983a) . In our patients operated by LAR, the mean distal surgical margin was 2.2 cm, with 11 (48%) patients having had a safety margin of less than 2 cm (min 0.3 cm). It is apparent that any increase in the proportion of restorative procedures could only occur at the expense of diminishing distal surgical margins. It is noteworthy that similar outcomes have been reported for patients with < 2 cm and those with >2 cm safety margins (Polett and Nicholls, 1983) , and it is not excluded that a narrower surgical margin will come to be considered oncologically acceptable following preoperative RT. The validity of this notion is already suggested by some series reporting good locoregional control with mean margins of 1.5 cm (Rouanet et al, 1995) , or for tumours located in the distal 2 cm of the rectum (Mohiuddin et al, 1998) . In the other hand, the quality of the circumferential surgical margin is known to be crucial for the oncological outcome (Quirke et al, 1986) . However, the minimum safe free lateral margin remains unknown (Heald and Karanjia, 1992) , particularly in conjunction with preoperative RT.
Considering the relatively advanced stage of patients in the present series, the 3-year locoregional control rate of 77.5% can be considered as satisfactory. Only two of 24 patients (8%) failed locally after restorative resections, consistent with the results of reported series using preoperative RT (Marks et al, 1993; Minsky et al, 1995; Rouanet et al, 1995) . The relatively low disease-free survival rate (58%) reflects the rather unfavourable initial disease presentation, with three patients already having distant metastases at time of surgery. No significant differences in outcomes were observed between the two surgical groups. However, it is noteworthy that patients presenting with marked pathological tumour response, with absent or only microscopic residual cancer after preoperative therapy, had a more favourable outcome. No locoregional recurrence and only one distant metastasis (8%) was observed in these 12 patients, compared with seven locoregional failures (17%) and 14 metastases (34%) in tumours showing no change or only partial response. Thus, as suggested by others (Berger et al, 1997) , post-RT down-staging may have a certain prognostic value. Whether the improved outcome can be attributed to the effect of preoperative therapy or to particular clinical or biological characteristics of the responding tumours remains speculative. a P-value refers to the Mann-Whitney U-tests testing for differences in medians (the means are given for informative purposes).
